Login
Cart
Support
Search
Search
Search
B. Ink
Appearances
View Grid
Bimekizumab in Patients with Psoriatic Arthritis: 3-Year Results for Overall and Tumor Necrosis Factor Inhibitor (TNFi)-Naïve Populations from a Phase 2b Open-Label Extension Study
Date
March 19, 2022
Speakers
P. J. Mease
A. Deodhar
J. F. Merola
I. B. McInnes
D. Assudani
R. Bajracharya
J. Coarse
B. Ink
G. Schett